Terunaga Nakagawa
-
Vanderbilt researchers receive Stanley Cohen Innovation Funding
Emily Hodges and Terunaga Nakagawa were named as the 2022 Stanley Cohen Innovation Fund recipients. Read MoreAug 31, 2022
-
The discovery of a ‘negative regulator’ in the brain alters understanding of brain function and potential treatment of cognitive disorders
Terunaga Nakagawa and the Vanderbilt Brain Institute discover new qualities of GSG1L, responsible for activity in the anterior thalamus. Read MoreJul 21, 2020
-
Study reveals mysteries of critical brain receptor complex
Poorly functioning AMPARs have been linked to a wide range of neurological and psychiatric disorders including seizures, Alzheimer’s disease, major depression and autism spectrum disorder. Understanding how AMPARs are formed and operate is essential for the rational design of pharmacological compounds that, by tuning AMPAR activity up or down, could improve treatment of these conditions. Read MoreDec 5, 2019
-
Grant bolsters Nakagawa’s research on autism, other brain disorders
Terunaga Nakagawa, M.D., Ph.D., associate professor of Molecular Physiology and Biophysics, has received a two-year, $100,000 grant from the Brain and Behavior Research Foundation to continue his studies of the molecular underpinnings of autism and other brain disorders. Read MoreApr 20, 2017
-
Study reveals neurotransmitter glutamate’s molecular structure
Terunaga Nakagawa, with colleagues from Japan and Oxford University in England, has discovered the bridgelike molecular structure of a mysterious glutamate receptor. Read MoreAug 11, 2016